Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma. - Ng SC; Moon JH; Park SS; Koh Y; Lee JH; Eom HS; Shin HJ; Jung SH; Do YR; Wilfred G; Husin A; Kim HJ; et al. (International journal of hematology, 2025)